Article

Association of rivaroxaban and rapamycin in patients with intramuscular venous malformations complicated with pain.

2022-10-19

Abstract excerpt

<h4>Background: </h4> In venous malformations (VM) the altered blood flow pattern due to a dysfunctional endothelium generates a prothrombotic state that will lead to localized intravascular coagulopathy (LIC), noticed by D-dimer elevation, pain, swelling and functional limitation. Rivaroxaban treatment prevents thrombin formation, preventing the constant stimulus for angiogenesis within the VM, stabilizing its gr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f1711e50-a638-5d93-9cf6-f16e98f64c7d
DOI: 10.22541/au.166618876.66211199/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Association of rivaroxaban and rapamycin in patients with intramuscular venous malformations complicated with pain.DOI 10.22541/au.166618876.66211199/v1Read

Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.Semantic proximity Read

Development of Molecular Therapies for Venous Malformations.Semantic proximity Read

Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.Semantic proximity Read

Targeted treatments for vascular malformations: current state of the art.Semantic proximity Read

Rapamycin and treatment of venous malformationsSemantic proximity Read

Vascular update: Morphogenesis, tumors, malformations, and molecular dimensionsSemantic proximity Read

Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapySemantic proximity Read

Clinical phenotype of adolescent and adult patients with extracranial vascular malformation.Semantic proximity Read

Analysis of the application value of endovascular interventional technology in the diagnosis and treatment of vascular malformations with limb hypertrophySemantic proximity Read

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.Semantic proximity Read

Update on pulmonary arteriovenous malformations.Semantic proximity Read

New and Emerging Targeted Therapies for Vascular Malformations.Semantic proximity Read